CIBC Bancorp USA’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
CIBC Bancorp USA's HAE Position: Q3 2026 in Review
CIBC Bancorp USA increased its Haemonetics (HAE) stake by 56% in Q3 2026, buying an estimated $180K and bringing the position to 5,402 shares worth $570K. The position accounts for ﹤0.01% of the portfolio, ranked #1295.
CIBC Bancorp USA first reported a position in HAE in Q3 2025 and has held it in 3 quarters since. 302 funds tracked by Wall St. Rank hold HAE as of Q3 2026.
- CIBC Bancorp USA held 5,402 shares of Haemonetics worth $570K as of Q3 2026.
- CIBC Bancorp USA bought 1,933 Haemonetics shares in Q3 2026, an estimated $180K.
- Haemonetics made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #1295 holding.
- CIBC Bancorp USA first reported a position in Haemonetics in Q3 2025 and has held it in 3 quarters since.
- 302 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.
Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.